Naurif

Naurif

Tablet

🧬 Granisetron 🏢 Square Pharmaceuticals PLC
Generic Name Granisetron
Manufacturer Square Pharmaceuticals PLC
Unit Price Unit Price: ৳ 28.19 (2 x 10: ৳ 563.80) Strip Price: ৳ 281.90

🔹 Indications

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

🔹 Pharmacology

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

🔹 Dosage & Administration

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

🔹 Interaction

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

🔹 Contraindications

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

🔹 Side Effects

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

🔹 Pregnancy & Lactation

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

🔹 Precautions & Warnings

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

🔹 Pediatric Usage

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

🔹 Storage Conditions

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vomiting.

Naurif Tablet is indicated for: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose of cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

💡 Frequently Asked Questions

Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vom...
Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vom...
Naurif Injection is indicated for: The prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, therapy including high dose cisplatin. The prevention and treatment of postoperative nausea and vom...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review